Loss of NF1 in MPNST leads to hyperactivation of RAS, however little is known about relevant downstream oncogenic signaling through RAF paralogs and effective targeted therapies in MPNST are still lacking. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.